Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3209519
Reference Type
Journal Article
Title
Diagnosis of latent tuberculosis by ELISPOT assay and tuberculin skin test
Author(s)
Du, F; Zhang, Z; Gao, T; Liu, Z; Jia, H; Xing, A; Du, B; Sun, Q; Cao, T; Zhang, Z
Year
2016
Is Peer Reviewed?
1
Journal
Medecine et Maladies Infectieuses
ISSN:
0399-077X
Language
English
PMID
27021933
DOI
10.1016/j.medmal.2016.02.011
Abstract
OBJECTIVE:
To determine the prevalence of latent tuberculosis infection (LTBI) in college students.
PATIENTS AND METHODS:
Four hundred and twenty newly admitted college students were enrolled. The Enzyme-Linked ImmunoSpot assay (ELISPOT) was used. Overall, 171 students with ELISPOT assay+/TST+ were monitored for three years to detect active TB disease.
RESULTS:
The overall positive rate of ELISPOT assay was 40.7% among TST+ students. The ELISPOT positive rates were 36.9%, 45.4%, and 64.3% in groups of TST induration of 10-14mm, 15-20mm, and ≥20mm, respectively, with a significant difference (χ(2)=10.136, P<0.01) but no significant difference between BCG scar and no scar (41.2% vs. 38.8%; P>0.05). None of the 171 untreated students contracted active TB within the three-year monitoring period.
CONCLUSION:
The LTBI rate might be overestimated by TST compared with interferon-γ release assays. On the basis of a close monitoring, few students developed active TB despite a positive result to the TST and ELISPOT assay.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity